Schrodinger (NASDAQ:SDGR) CFO Sells $21,039.90 in Stock

Schrodinger, Inc. (NASDAQ:SDGR) CFO Rachit Jain sold 1,631 shares of the company’s stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $12.90, for a total transaction of $21,039.90. Following the completion of the transaction, the chief financial officer owned 52,596 shares in the company, valued at approximately $678,488.40. This represents a 3.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Schrodinger Stock Performance

Shares of NASDAQ SDGR traded down $0.29 during mid-day trading on Friday, reaching $12.74. The company had a trading volume of 976,433 shares, compared to its average volume of 1,475,655. Schrodinger, Inc. has a twelve month low of $11.11 and a twelve month high of $27.63. The stock’s 50 day moving average is $14.88 and its 200-day moving average is $17.65. The stock has a market capitalization of $938.56 million, a PE ratio of -8.97 and a beta of 1.57.

Schrodinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.57. The company had revenue of $87.24 million for the quarter, compared to analyst estimates of $83.66 million. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The business’s revenue was up 4.7% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.24) EPS. On average, sell-side analysts anticipate that Schrodinger, Inc. will post -2.37 EPS for the current year.

More Schrodinger News

Here are the key news stories impacting Schrodinger this week:

• Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
• Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (≈1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
• Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (≈3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
• Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
• Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings

Wall Street Analysts Forecast Growth

SDGR has been the subject of several analyst reports. UBS Group started coverage on shares of Schrodinger in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $18.00 price objective for the company. TD Cowen reiterated a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. KeyCorp lowered their price objective on Schrodinger from $28.00 to $25.00 and set an “overweight” rating on the stock in a report on Thursday, January 8th. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a report on Friday, January 9th. Finally, Wall Street Zen raised Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Four analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $21.75.

Hedge Funds Weigh In On Schrodinger

Large investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC boosted its position in shares of Schrodinger by 722.8% during the 4th quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company’s stock valued at $25,000 after acquiring an additional 1,207 shares in the last quarter. Los Angeles Capital Management LLC acquired a new stake in Schrodinger during the fourth quarter valued at approximately $26,000. Hantz Financial Services Inc. grew its stake in shares of Schrodinger by 5,025.8% in the 4th quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company’s stock valued at $28,000 after purchasing an additional 1,558 shares during the period. Fideuram Intesa Sanpaolo Private Banking S.P.A. acquired a new position in shares of Schrodinger in the 4th quarter worth approximately $36,000. Finally, Aster Capital Management DIFC Ltd lifted its position in shares of Schrodinger by 212.4% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock worth $39,000 after buying an additional 1,321 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.